The clinician's guide to randomized trials: interpretation
Eye (Lond)
.
2022 Mar;36(3):481-482.
doi: 10.1038/s41433-021-01866-7.
Epub 2022 Jan 21.
Authors
Alex Thabane
1
,
Mark R Phillips
1
,
Tien Y Wong
2
,
Lehana Thabane
1
3
,
Mohit Bhandari
1
4
,
Varun Chaudhary
5
6
;
Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group
Collaborators
Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group
:
Charles C Wykoff
,
Sobha Sivaprasad
,
Peter Kaiser
,
David Sarraf
,
Sophie Bakri
,
Sunir J Garg
,
Rishi P Singh
,
Frank G Holz
,
Robyn H Guymer
Affiliations
1
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
2
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
3
Biostatistics Unit, St. Joseph's Healthcare-Hamilton, Hamilton, Ontario, Canada.
4
Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
5
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
[email protected]
.
6
Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
[email protected]
.
PMID:
35058599
PMCID:
PMC8873262
DOI:
10.1038/s41433-021-01866-7
No abstract available
Publication types
Editorial
MeSH terms
Humans
Randomized Controlled Trials as Topic*